MHMarc De Hert

Marc De Hert

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marc De Hert has a total of 224 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Psychotropic medication use, lifestyle, genetic risk for high BMI and the incidence of cardiovascular disease

    by Nini de Boer, Iris Hanskamp, Bochao Danae Lin, Liese Boonstra, Marte van der Horst, Kristel van Eijk, Marco P. Boks, Wouter J. Peyrot, Jos Twisk, Thomas Goldschmidt, et al.

  • Open Access

    Genetic sensitivity to the environment moderates the impact of positive and negative childhood experiences on psychological adjustment “for good and for bad”

    by Pilar Torrecilla, Valeria Lavín, Angelo Arias-Magnasco, Bochao Danae Lin, Claudia Menne-Lothmann, Jeroen Decoster, Ruud van Winkel, Dina Collip, Philippe Delespaul, Marc De Hert, et al.

    Background: The vulnerability–stress framework guiding gene–environment interaction (GxE) research overlooks the role of positive experiences. The Differential Susceptibility (DS) model offers a broader perspective, suggesting that individuals vary in sensitivity to both negative and positive environments. This study aimed at replicating previous DS research by examining interactions between polygenic scores for environmental sensitivity (PGS-ES) and positive and negative early exposures on subclinical psychosis and internalizing psychopathology, functioning, and wellbeing. Methods: The sample consisted of 638 twins from the first wave of the TwinssCan study, a general population twin cohort. PGS-ES and adversity, bullying and positive experiences in childhood were collected, along with assessments of psychotic, affective, functioning, and positive mental health. GxE interactions were tested under a competitive–confirmatory approach. Results: DS effects were found for the interactions between PGS-ES and all environmental exposures on schizotypic eccentricity and functioning. Adolescents with high genetic sensitivity were rated as more eccentric and less functional under childhood adversity but were rated as less eccentric and better adjusted under childhood favorable conditions. DS also resulted from the interaction between PGS-ES and positive childhood on social coping. No significant models emerged for internalizing or wellbeing. Conclusion: Findings overall supported DS, indicating that genetic sensitivity to the environment operates in a “for better and for worse” manner depending on the quality of environmental exposures. It extends initial evidence that DS applies to nonclinical psychosis expression and highlights the importance of considering the full spectrum of environmental conditions to understand both risk and opportunity factors in GxE.

  • Open Access

    Sex differences in the effect of childhood adversity and coping strategies on psychosis expression: A TwinssCan study

    by Melike Karaçam Doğan, Thanavadee Prachason, Laura Fusar-Poli, Claudia Menne-Lothmann, Jeroen Decoster, Ruud van Winkel, Dina Collip, Philippe Delespaul, Marc De Hert, Catherine Derom, et al.

    Background: Sex differences in psychosis pathoetiology are insufficiently understood. This study explores how childhood adversity (CA) and coping mechanisms relate to psychosis expression (PE) across males and females in the general population. Methods: Data from the TwinssCan project (males: n = 312; females: n = 478) were used. The Childhood Trauma Questionnaire assessed CA domains. The Utrecht Coping List assessed coping strategies. Psychosis expression was assessed using the Community Assessment of Psychic Experiences (CAPE). Mixed linear regression analyses examined sex-stratified associations of CAPE scores with CA, coping strategies, and their interactions. Results: Emotional abuse (EA) was associated with increased total CAPE scores (T-CAPE), explaining the greatest variance among CA across sexes. Sex-specific effects showed that sexual abuse (SA) and physical abuse (PA) were linked to higher T-CAPE in females, whereas physical neglect (PN) was linked to higher T-CAPE in males. Passive-reacting was associated with increased T-CAPE, explaining the greatest variance among coping styles across both sexes. Sex-specific effects showed that, in females, seeking social support was linked to decreased T-CAPE, while emotional expression increased it. The only sex-shared interaction effect was between reassuring thoughts and emotional neglect (EN), associated with decreased T-CAPE. In females, social support (× PA/PN/EA), reassuring thoughts (× PA/PN), and palliative-reacting (× PN/PA) were associated with decreased T-CAPE, while passive-reacting (× EN) increased it. In males, avoidance (× SA/PA) and passive-reacting (× PN) were associated with increased T-CAPE. Conclusions: Sex differences in the associations of PE with CA and coping underscore the necessity for sex-specific interventions that promote adaptive coping strategies.


  • Open Access

    Cultural psychiatry in Flanders, Belgium: an exploratory focus group study and position statement

    by Ruben Willems, Niels Albert, Kris Van Den Broeck, Peter Niemegeers, Maarten Van Den Bossche, Sana Sadat Mohammad Rafael Nazari, Lukas Claus, Seline Van Den Ameele, Johan Detraux, Marc De Hert, et al.

    Background: As in other European countries, mental healthcare in Belgium has to deal with the increasing cultural diversity that exists within society. However, commitment of the Belgian healthcare system toward cultural diversity remains weak, and clear guidelines on culturally competent psychiatric practice are still lacking. Methods: Three focus groups with professional caregivers, three with adult patients, and one with young adults in the transition age were organized. The seven focus groups each consisted of 5–10 participants. Two brainstorming sessions with a total of 15 experts were organized a priori to delineate focus group topics. Data analysis software MAXQDA 24 was used for thematic analysis. Results: The thematic tree consists of the central theme “culturally sensitive mental healthcare” with five main themes (i.e., vulnerable population, language barrier, mental healthcare stigma, spirituality/religion, Western vs non-Western frame of reference). These themes are further stratified into a number of subthemes and one overarching theme (i.e., diversity policy). The themes have resulted in six recommendations to improve cultural psychiatric care. These recommendations underscore the vulnerability of the target patient population, specific training needs, the need for professional interpreters and intercultural mediators, the place of religion and spirituality in therapy, reflexivity as core competence, and the need to establish reference centers. Conclusions: The six recommendations provide a scientifically sound base to develop focused and effective mental health policies at the governmental, organizational, and patient level. Continued attention to the importance of cultural sensitivity in mental healthcare provision remains important, particularly in countries that are lagging behind.


  • Top Cited Papers
    Open Access

    Smoking cessation for people with severe mental illness: systematic review and network meta-analysis

    by Geertruida E Bekkering, Johan Detraux, José A López-López, Marc De Hert, A Eden Evins, Anne-Catherine Vanhove, Hanne Cloetens, Abdullah M Algarni, Thomas Vandendriessche, Arnav Agarwal, et al.

    Objective: To evaluate the comparative effectiveness and safety of pharmacological and non-pharmacological smoking cessation interventions in people with severe mental illness Design: Systematic review and network meta-analysis. Data sources: Medline, Embase, Scopus, Cochrane Central Register of Controlled Trials (CENTRAL), and Web of Science, from inception to 19 September 2024. Eligibility criteria for selecting studies: Trials enrolling adults who had established diagnoses of schizophrenia, bipolar disorder, recurrent or current severe major depressive disorder, or post-traumatic stress disorder, randomised to a smoking cessation intervention versus another active treatment, placebo, standard care, or no treatment. Results: 74 randomised controlled trials (11 023 participants) evaluating nine smoking cessation interventions were included in the study. Compared with placebo or minimal care, varenicline (10 more per 100 achieving long term smoking abstinence, 95% confidence interval (CI) 5 to 16; high certainty evidence) and bupropion (5 more per 100, 1 to 10; moderate certainty evidence) increased long term abstinence. Effects on short term smoking abstinence were similar. Nicotine replacement therapy improved short term abstinence but with little or no long term abstinence benefit (moderate certainty evidence). Combination interventions (pharmacological with non-pharmacological interventions) may increase long term abstinence (6 more per 100, 95% CI 3 to 11; low certainty evidence). The certainty of evidence for other interventions was very low. Serious adverse event data were highly uncertain. Dropout from a trial because of harms was possibly no different for varenicline, bupropion, and nicotine replacement therapy compared with placebo or minimal care. Conclusions: Varenicline, bupropion, and nicotine replacement therapy likely improved smoking abstinence in people with severe mental illness compared with placebo or minimal care (moderate to high certainty evidence). Combined pharmacological and non-pharmacological approaches may offer more benefit (low certainty evidence), but the risk of serious adverse events for all interventions was very uncertain. Systematic review registration: PROSPERO CRD42022349498.


  • Open Access

    Shared genetic and environmental influences on altered functional connectivity and schizophrenia liability

    by Karis Colyer-Patel, Jalmar Teeuw, Rachel Brouwer, Marc Bohlken, Marc De Hert, Wiepke Cahn, Rene Kahn, Hilleke Hulshoff Pol

    Schizophrenia is characterised by dysconnectivity of several resting-state functional brain networks, potentially reflecting reduced efficiency of brain communication. It remains unclear to what extent dysconnectivity is influenced by genetic or environmental liabilities to develop the disease. This study investigated whether such dysconnectivity indicates genetic liability or environmental risk of schizophrenia and its relation to cognitive functioning. Resting-state fMRI at 3T was measured in 71 individual twins discordant for schizophrenia and 154 individual matched healthy control twins. Functional connectivity was calculated within and between eight cortical networks and seven subcortical regions. Structural equation modelling assessed the heritability of connectivity, and its phenotypic, genetic, shared environmental and unique environmental associations with schizophrenia liability, as well as its relation to cognitive functioning. Phenotypic associations with increased schizophrenia liability were found in 12 connections (11%), with 8 showing hyperconnectivity and 4 hypo-connectivity. Two connections were partly explained by genetic overlap between disease liability and connectivity, i.e., hyperconnectivity of the sensorimotor-thalamic connection; hypoconnectivity of the sensorimotor-hippocampal connection. Five connections were partly explained by unique environmental overlap with schizophrenia liability, i.e., hyperconnectivity of the dorsal attention-thalamic, visual-thalamic and amygdala-accumbens connections; hypoconnectivity of the sensorimotor-hippocampal and default mode-salience connections. Increased hyperconnectivity was associated with lower cognitive functioning in this cohort enriched for schizophrenia. Dysconnectivity between functional brain networks is present with increased schizophrenia liability, with both hyper- and hypo-connectivity due to genetic and unique environmental influences. Hyperconnectivity between networks is related to lower cognitive functioning and may constitute a genetic or environmental marker for increased schizophrenia liability.

  • Open Access

    End-of-life care for people with severe and persistent mental illness and a life-limiting disease: An umbrella review

    by Jonas Denduyver, Johan Detraux, Justien Weydts, Marc De Hert

    Background: It is widely known that people with a severe and persistent mental illness (SPMI) are more at risk of poor physical health outcomes because of disparities in healthcare access and provision. Less is known about the quality of end-of-life (EoL) care in people with SPMI who have a life-limiting disease. Methods: A comprehensive and systematic literature search in PubMed, Embase, Web of Science, Scopus, and CINAHL electronic databases (from inception to November 2023) was conducted, without language restriction, for reviews on EoL care and/or palliative sedation for people with SPMI and a life-limiting disease. A critical appraisal of the selected reviews was performed. Data were analyzed according to the four principles of biomedical ethics. Results: Ten reviews were included. These show that people with SPMI are at risk of suboptimal EoL care. Stigma among healthcare professionals, lack of integrated care policies, absence of advanced care planning, and insufficient expertise and training in palliative care of psychiatrists have been identified as key challenges to the provision of adequate EoL care for people with SPMI. No data were found about palliative sedation. Conclusions: To optimize palliative and EoL care for SPMI patients with a life-limiting disease, a policy of coordinated and integrated mental and physical healthcare is needed. Moreover, education and training initiatives to reduce stigma and discrimination among all healthcare workers and to enhance palliative care skills in psychiatrists should be offered. Finally, more research is needed on EoL particularly on palliative sedation for people with SPMI and a life-limiting disease.


  • Open Access

    Prevalence, nature, and determinants of COVID-19-related conspiracy theories among healthcare workers: a scoping review

    by Hanne Loyens, Johan Detraux, Marc De Hert

    Background: COVID-19-related conspiracy theories (CTs) have been observed among healthcare workers (HCWs). There exists, however, a lack of research investigating the extent, nature, and determinants of CTs among HCWs worldwide. Methods: A systematic literature search of Medline, EMBASE, Web of Science, Scopus, and CINAHL electronic databases (from inception to October 2023) was conducted for studies examining the prevalence and nature of COVID-19-related CTs among HCWs and health students and/or factors driving HCWs into believing these CTs. Results: Prevalence rates of COVID-19-related CTs among HCWs varied widely across studies, ranging from 0.89% to 75.6%. These prevalence rates mainly concern vaccine-hesitant HCWs (although a minority of vaccinated HCWs also endorse CTs). Higher prevalence rates of CTs were found in the Arab world, Ethiopia, and Nigeria, compared to other African and Western countries. While in European countries and Northern America, an increased belief of HCWs in the “destabilization and power gain” narrative was found, African HCWs particularly endorsed the “population reduction” and “liberty restriction” narratives. Limited and heterogeneous data prevented conclusive findings on the relationship between CTs and sociodemographic factors, ethnicity, and psychological traits among HCWs. However, a consistent observation emerged regarding the level of education, indicating HCWs with higher educational attainment (e.g., physicians) tend to endorse CTs less frequently. Conclusion: Although COVID-19-related CTs may be highly prevalent among vaccine-hesitant HCWs, gaps in understanding the drivers of CTs among HCWs remain. Given HCWs’ critical role in public health, especially during pandemics, further research is therefore essential.


  • Open Access

    Attenuated mental symptoms in the general population: first data from the observational cross-sectional ATTENTION study in Greece

    by Michaela Koummati, Jelena Vrublevska, Marc De Hert, Allan H. Young, Paolo Fusar-Poli, Rajiv Tandon, Afzal Javed, Konstantinos N. Fountoulakis

    Background: It has been reported that abnormal experiences could be common in the general “healthy” population, with the vast majority of individuals never proceeding to manifest a frank mental disorder. Aims: This study aimed to quantify subthreshold psychiatric symptoms in the general population. Methods: The protocol included clinicodemographic data and a mental symptoms questionnaire, and additionally, the CES-D, STAI-S, RASS, and the GloDiS to assess depression, anxiety, suicidality, and functional impairment, respectively. The data were collected online and anonymously from 1504 persons (75.66% females; 23.73% males). Descriptive statistics, risk ratios, and factor analysis were utilized. Results: Clinical depression was present in approximately 10%, any somatic disorder in 20.21% (9.90% both), and a history of any mental disorder was present in 42.75%. The healthy individuals (46.94% of the study sample) were experiencing distress (8.6%) and subthreshold mental symptoms (attenuated psychotic, schizotypal distrust, emotional lability, conformity, and interpersonal and social functioning). Attenuated psychotic symptoms are present in almost 10%, and the conversion rate to any kind of psychosis was probably 0.5% per year until the age of 40, with one-third of these persons eventually converting. Beyond the age of 40, no conversion to psychosis seems to occur. All aspects of symptoms correlated weakly but significantly with aspects of functional impairment. Conclusions: The results of the current study are in accord with the literature and suggest that a significant number of persons in the general population experience attenuated psychiatric symptoms and mild functional impairment without ever manifesting an overt mental disorder. There is a need for further research on this matter to confirm these findings and to explore their implications both for mental and somatic health and the provision of health care.


  • Open Access

    The epidemiology and phenomenology of non-antipsychotic-induced dystonia: a hybrid systematic-narrative review

    by Kirsten Catthoor, Johan Detraux, Marc De Hert

    Background: Medication-induced dystonia (MID) is a movement disorder (MD), characterized by involuntary sustained or intermittent muscle contractions, causing abnormal, often repetitive, movements, postures, or both. Although MID is commonly associated with the use of antipsychotics, it also occurs with many other medications widely used in clinical practice. Methods: A systematic literature search (from inception to November 2023), using the PubMed and Embase databases, was conducted without language restriction for articles reporting on MID in people without pre-existing MDs, and this for all potentially relevant non-antipsychotic medications. A narrative synthesis of the available evidence was undertaken. Results: MID is common (1 to 10%) with certain antiemetics. Selective serotonin reuptake inhibitors and the antiepileptics valproate, carbamazepine, and lamotrigine are rarely (0.01 to 0.1%) or very rarely (<0.01%) associated with MID. All other medications are very rarely (<0.01%) associated with MID or have a risk that cannot be precisely estimated. The actual rate of dystonic reactions with most non-antipsychotic agents remains unknown, owing to misdiagnosis and underreporting in the scientific literature. In general, MID seems to occur more often in children and adolescents, even with a single low dose, and with polymedication. In most cases, MID is acute in onset (occurring within hours to days) and involves the head and neck. Conclusions: Although MID is most common with dopamine receptor-blocking antiemetics, many other medications may also produce dystonic reactions, particularly in children and adolescents. Although such incidents remain rare, there are indications that MID is underreported for many classes of medications.